Entera Bio Ltd.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $7.5M | $8.6M |
| FY2021 | — | $22.6M | $24.9M |
| FY2022 | — | $11.8M | $12.3M |
| FY2023 | — | $10.4M | $11.0M |
| FY2024 | — | $8.1M | $8.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $7.5M | $8.6M |
| FY2021 | — | $22.6M | $24.9M |
| FY2022 | — | $11.8M | $12.3M |
| FY2023 | — | $10.4M | $11.0M |
| FY2024 | — | $8.1M | $8.7M |